Microbiology of Diabetic Foot Infections in a Tertiary Care Hospital in Sao Paulo, Brazil

Imagem de Miniatura
Arquivos
art_PALOMO_Microbiology_of_Diabetic_Foot_Infections_in_a_Tertiary_2022.PDF (255.95 KB)
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
MDPI
Autores
PALOMO, Amanda Thurler
PIRES, Ana Paula Maia
MATIELO, Marcelo Fernando
SOARES, Rafael de Athayde
PECEGO, Christiano
SACILOTTO, Roberto
PAULA, Alexandre Inacio de
HOSINO, Nair
GAMBA, Cristiano de Melo
FONSECA, Cibele Lefreve
Citação
ANTIBIOTICS-BASEL, v.11, n.8, article ID 1125, 8p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Diabetic foot infections (DFIs) are one of the causes of hospitalization in diabetic patients and, when this occurs, empirical antibiotic therapy is necessary. We have conducted a retrospective study of patients with DFI that required hospitalization to evaluate microbiologic profile and the susceptibility pattern of these infections. We evaluated 320 patients, of which 223 (69.7%) were male with a media age of 71 years with 276 isolates. Gram-positive bacteria were responsible for 188 (68.1%) of the isolates, while Gram-negative bacilli were responsible for 88 (31.9%). E. faecalis was the most prevalent pathogen, followed by S. aureus and coagulase negative Staphylococci. Among Gram-negative pathogens, P. aeruginosa was the most prevalent agent. Regarding the susceptibility profile, we found ampicillin-sensitive enterococci in 89% of the cases, oxacillin-sensitive S. aureus in 47%, but in coagulase-negative staphylococci, oxacillin was sensible only in 20%. The susceptibility profile of Gram-negatives was very good with 76% susceptibility of P. aeruginosa to ceftazidime and meropenem. The other prevalent Enterobacterales had great susceptibility to ceftazidime, piperacillin-tazobactam and 100% susceptibility to meropenem, with the exception of K. pneumoniae, which had 75% susceptibility to meropenem. Knowledge of microbiological profile and susceptibility patterns of patients with DFIs is useful to guide empirical therapy.
Palavras-chave
diabetic foot infections, microbiology, epidemiology
URI
https://observatorio.fm.usp.br/handle/OPI/49252
Referências
  1. [Anonymous], 2016, WHO GLOB REP DIAB, P20
  2. Armstrong DG, 1998, DIABETES CARE, V21, P855, DOI 10.2337/diacare.21.5.855
  3. Baig MS, 2022, LIFE-BASEL, V12, DOI 10.3390/life12071054
  4. Bezerra CB, 2020, DIABETES RES CLIN PR, V159, DOI 10.1016/j.diabres.2019.107945
  5. Boccella M, 2021, ANTIBIOTICS-BASEL, V10, DOI 10.3390/antibiotics10121552
  6. Causey MW, 2016, J VASC SURG, V63, P1563, DOI 10.1016/j.jvs.2016.01.011
  7. Cerqueira Lorena de Oliveira, 2020, J. vasc. bras., V19, pe20190070, DOI 10.1590/1677-5449.190070
  8. Darling JD, 2017, J VASC SURG, V65, P695, DOI 10.1016/j.jvs.2016.09.055
  9. Darwis I, 2021, MALAYS J MED SCI, V28, P42, DOI 10.21315/mjms2021.28.5.4
  10. Di Gennaro F, 2020, J GLOB ANTIMICROB RE, V23, P167, DOI 10.1016/j.jgar.2020.08.022
  11. Dorr S, 2021, ACTA DIABETOL, V58, P181, DOI 10.1007/s00592-020-01587-5
  12. Santos Vanessa Prado dos, 2019, J. vasc. bras., V18, pe20190063, DOI 10.1590/1677-5449.190063
  13. Du F, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.881659
  14. Hatipoglu M, 2014, EUR J CLIN MICROBIOL, V33, P871, DOI 10.1007/s10096-014-2047-5
  15. Hawkins B.K., 2022, FOOT, V51, P101877, DOI [10.1016/j.foot.2021.101877, DOI 10.1016/J.FOOT.2021.101877]
  16. Karthik Subramaniam, 2022, Foot (Edinb), V52, P101878, DOI 10.1016/j.foot.2021.101878
  17. Lipsky BA, 2012, CLIN INFECT DIS, V54, pE132, DOI [10.1093/cid/cis346, 10.1093/cid/cis460]
  18. Mackintosh CL, 2011, J ANTIMICROB CHEMOTH, V66, P408, DOI 10.1093/jac/dkq445
  19. Mathioudakis N, 2017, J VASC SURG, V65, P1698, DOI 10.1016/j.jvs.2016.12.123
  20. Mills JL, 2014, J VASC SURG, V59, P220, DOI 10.1016/j.jvs.2013.08.003
  21. Monteiro-Soares M, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3273
  22. Mponponsuo K, 2021, ADV SKIN WOUND CARE, V34, P574, DOI 10.1097/01.ASW.0000791876.10485.d4
  23. Nascimento LD, 2021, INT J LOW EXTR WOUND, DOI 10.1177/15347346211050771
  24. Perim MC, 2015, REV SOC BRAS MED TRO, V48, P546, DOI 10.1590/0037-8682-0146-2015
  25. Permana H, 2022, ACTA MED INDONES, V54, P247
  26. Plusch D, 2015, J FOOT ANKLE RES, V8, DOI 10.1186/s13047-015-0120-7
  27. PONTES DÊNISSON GUEDES, 2020, Rev. Col. Bras. Cir., V47, pe20202471, DOI 10.1590/0100-6991e-20202471
  28. Rastogi A, 2017, J DIABETES COMPLICAT, V31, P407, DOI 10.1016/j.jdiacomp.2016.11.001
  29. Robinson WP, 2017, J VASC SURG, V66, P488, DOI 10.1016/j.jvs.2017.01.063
  30. Thabit AK, 2019, INT J INFECT DIS, V81, P128, DOI 10.1016/j.ijid.2019.02.005
  31. Truong-Thanh P, 2022, ANN SURG, V276, P233, DOI 10.1097/SLA.0000000000005205
  32. van Haelst STW, 2018, J VASC SURG, V68, P1104, DOI 10.1016/j.jvs.2018.02.028
  33. Wagner F W Jr, 1981, Foot Ankle, V2, P64
  34. Yang WY, 2018, DIABETES CARE, V41, P917, DOI 10.2337/dci18-0007

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/49
Artigos e Materiais de Revistas Científicas - ODS/03